Plexxikon Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 65

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $935M

Plexxikon General Information

Description

Manufacturer of small molecule pharmaceutical products designed to treat human disease. The company's products are used for the treatment of melanoma and colorectal cancer; and for the treatment of pain, polycystic kidney disease, rheumatoid arthritis, metastatic breast cancer, and renal disease. enabling doctors to provide treatment for metabolic diseases, such as obesity indications; oncology, such as osteolytic metastatic disease; and CNS, such as multiple sclerosis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 329 Oyster Point
  • South San Francisco, CA 94080
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 329 Oyster Point
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Plexxikon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 04-Apr-2011 $935M Completed Generating Revenue
4. Later Stage VC (Series B2) 03-Nov-2009 Completed Generating Revenue
3. Later Stage VC (Series B1) 08-Mar-2005 Completed Startup
2. Early Stage VC 15-Jan-2003 $31.1M $31.1M Completed Startup
1. Early Stage VC Completed Startup
To view Plexxikon’s complete valuation and funding history, request access »

Plexxikon Patents

Plexxikon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230081426-A1 Compounds and methods for kras modulation and indications therefor Inactive 18-Sep-2020
WO-2022061251-A1 Compounds and methods for kras modulation and indications therefor Inactive 18-Sep-2020
JP-2023542473-A Combination drug anticancer treatment Pending 21-Aug-2020
CA-3192047-A1 Combinational drug anticancer therapies Pending 21-Aug-2020
WO-2022040512-A1 Combinational drug anticancer therapies Inactive 21-Aug-2020 A61K31/58
To view Plexxikon’s complete patent history, request access »

Plexxikon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Plexxikon Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Advanced Technology Ventures Venture Capital Minority
Alta Partners Venture Capital Minority
Astellas Venture Management Corporate Venture Capital Minority
Bock Family Ventures Venture Capital Minority
CW Group Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Plexxikon FAQs

  • When was Plexxikon founded?

    Plexxikon was founded in 2000.

  • Where is Plexxikon headquartered?

    Plexxikon is headquartered in South San Francisco, CA.

  • What is the size of Plexxikon?

    Plexxikon has 65 total employees.

  • What industry is Plexxikon in?

    Plexxikon’s primary industry is Pharmaceuticals.

  • Is Plexxikon a private or public company?

    Plexxikon is a Private company.

  • What is the current valuation of Plexxikon?

    The current valuation of Plexxikon is .

  • What is Plexxikon’s current revenue?

    The current revenue for Plexxikon is .

  • How much funding has Plexxikon raised over time?

    Plexxikon has raised $61.1M.

  • Who are Plexxikon’s investors?

    Advanced Technology Ventures, Alta Partners, Astellas Venture Management, Bock Family Ventures, and CW Group are 5 of 9 investors who have invested in Plexxikon.

  • When was Plexxikon acquired?

    Plexxikon was acquired on 04-Apr-2011.

  • Who acquired Plexxikon?

    Plexxikon was acquired by Daiichi Sankyo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process